Allogene Therapeutics (ALLO) Income Statement (2018 - 2026)
Income Statement report data from Mar 31, 2018 to Mar 31, 2026 for Allogene Therapeutics (ALLO).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (-33.33%) | 30K | -40.00K | 50K (-44.44%) | 90K (+50.00%) | 60K (-99.92%) | 76M (+151200.00%) | 50K (+25.00%) | 40K (-99.90%) | 38M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||||||
Research And Development | 32M (+11.77%) | 29M (-8.12%) | 31M (-22.41%) | 40M (-20.00%) | 50M (+11.63%) | 45M (+0.58%) | 45M (-11.22%) | 50M (-3.64%) | 52M (-4.39%) | 55M (+18.88%) | 46M (-25.89%) | 62M (-22.68%) | 80M (+6.39%) | 75M (+18.51%) | 64M (+11.32%) | 57M (-4.97%) | 60M (+11.45%) | 54M (-8.07%) | 59M (+12.30%) | 52M (-5.24%) | 55M (+5.65%) | 52M (+1.58%) | 51M (+8.71%) | 47M (+12.51%) | 42M (-14.83%) | 49M (+23.43%) | 40M (+25.87%) | 32M (+35.77%) | 23M (+26.49%) | 19M (+70.19%) | 11M (-91.13%) | 122M | - |
Selling General And Administrative | 14M (+2.32%) | 14M (+0.22%) | 14M (-3.78%) | 14M (-4.74%) | 15M (-3.41%) | 16M (-4.96%) | 16M (+1.49%) | 16M (-6.83%) | 17M (+0.29%) | 17M (+1.06%) | 17M (-7.99%) | 19M (-1.91%) | 19M (-10.10%) | 21M (+11.11%) | 19M (-3.13%) | 20M (-1.96%) | 20M (-0.30%) | 20M (+5.05%) | 19M (+1.17%) | 19M (+14.79%) | 16M (-4.50%) | 17M (+3.07%) | 17M (+4.79%) | 16M (+1.41%) | 16M (+2.83%) | 15M (+1.26%) | 15M (+5.85%) | 14M (+8.65%) | 13M (-10.18%) | 15M (+28.45%) | 11M (-9.66%) | 13M (+381.92%) | 2.60M |
Operating Expenses | 46M (+8.70%) | 42M (-5.57%) | 45M (-20.98%) | 57M (-12.84%) | 65M (+7.77%) | 60M (-15.72%) | 72M (+0.48%) | 71M (+2.73%) | 70M (-18.32%) | 85M (+35.08%) | 63M (-21.77%) | 81M (-18.72%) | 99M (+2.80%) | 96M (+16.82%) | 83M (+7.64%) | 77M (-4.21%) | 80M (+8.26%) | 74M (-4.86%) | 78M (+9.36%) | 71M (-0.67%) | 72M (+3.16%) | 69M (+1.94%) | 68M (+7.73%) | 63M (+9.50%) | 58M (-10.68%) | 65M (+17.40%) | 55M (+19.69%) | 46M (+26.06%) | 36M (+10.32%) | 33M (+48.94%) | 22M (-83.56%) | 135M (+5092.69%) | 2.60M |
Depreciation And Amortization | 2.87M (-69.01%) | 9.26M | - | - | 3.10M (-69.25%) | 10M | - | - | 3.56M (-66.70%) | 11M | - | - | 3.51M (-66.92%) | 11M | - | - | 3.69M (-56.99%) | 8.58M | - | - | 1.92M (-65.15%) | 5.51M | - | - | 1.89M (-53.45%) | 4.06M | - | - | 540K (-46.00%) | 1.00M | - | - | - |
Operating Income | |||||||||||||||||||||||||||||||||
Operating Income | -46.09M (+8.70%) | -42.40M (-5.57%) | -44.90M (-20.98%) | -56.82M (-12.84%) | -65.19M (+7.77%) | -60.49M (-15.72%) | -71.77M (+0.48%) | -71.43M (+2.78%) | -69.50M (-18.34%) | -85.11M (+35.10%) | -63.00M (-21.78%) | -80.54M (-18.72%) | -99.09M (+2.73%) | -96.46M (+16.94%) | -82.49M (+7.70%) | -76.59M (-4.25%) | -79.99M | 1.71M | -77.67M (+9.35%) | -71.03M (+113.95%) | -33.20M (-52.13%) | -69.36M (+1.94%) | -68.04M (+7.73%) | -63.16M (+9.50%) | -57.68M (-10.67%) | -64.57M (+17.38%) | -55.01M (+19.69%) | -45.96M (+26.06%) | -36.46M (+10.32%) | -33.05M (+48.94%) | -22.19M (-83.56%) | -135.01M (+5092.69%) | -2.60M |
Ebit | -46.09M (+8.70%) | -42.40M (-5.57%) | -44.90M (-20.98%) | -56.82M (-12.84%) | -65.19M (+7.77%) | -60.49M (-15.72%) | -71.77M (+0.48%) | -71.43M (+2.78%) | -69.50M (-18.34%) | -85.11M (+35.10%) | -63.00M (-21.78%) | -80.54M (-18.72%) | -99.09M (+2.73%) | -96.46M (+16.94%) | -82.49M (+7.70%) | -76.59M (-4.25%) | -79.99M | 1.71M | -77.67M (+9.35%) | -71.03M (+113.95%) | -33.20M (-52.13%) | -69.36M (+1.94%) | -68.04M (+7.73%) | -63.16M (+9.50%) | -57.68M (-10.67%) | -64.57M (+17.38%) | -55.01M (+19.69%) | -45.96M (+26.06%) | -36.46M (+10.32%) | -33.05M (+48.94%) | -22.19M (-83.56%) | -135.01M (+5092.69%) | -2.60M |
EBITDA | -43.22M (+0.21%) | -43.13M (+5.04%) | -41.06M (-18.97%) | -50.67M (-18.39%) | -62.09M (+1.69%) | -61.06M (-7.75%) | -66.19M (-0.26%) | -66.36M (+0.62%) | -65.95M (-13.71%) | -76.43M (+22.70%) | -62.29M (-21.38%) | -79.23M (-17.11%) | -95.58M (+9.86%) | -87.00M (+4.63%) | -83.15M (+11.18%) | -74.79M (-1.98%) | -76.30M | 11M | -78.19M (+10.22%) | -70.94M (+126.79%) | -31.28M (-53.92%) | -67.88M (+2.54%) | -66.20M (+8.58%) | -60.97M (+9.28%) | -55.79M (-19.60%) | -69.39M (+36.86%) | -50.70M (+22.46%) | -41.40M (+15.26%) | -35.92M (+152.96%) | -14.20M (-64.62%) | -40.14M (-70.24%) | -134.90M (+5088.46%) | -2.60M |
Other Income / Expenses | |||||||||||||||||||||||||||||||||
Interest Expense | 300K (-3.23%) | 310K (-8.82%) | 340K (+25.93%) | 270K (+80.00%) | 150K (+87.50%) | 80K (-20.00%) | 100K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.36M | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.36M | - | - |
Other Non Operating Income | 210K (-4.55%) | 220K | -80.00K (+100.00%) | -40.00K | 90K | -3.92M (+250.00%) | -1.12M | 90K | -930.00K (-94.78%) | -17.83M (+224.18%) | -5.50M (+122.67%) | -2.47M | 2.06M | -9.44M (+468.67%) | -1.66M | 1.49M (+204.08%) | 490K | -3.57M (+292.31%) | -910.00K (+71.70%) | -530.00K | 510K (-94.43%) | 9.16M (+355.72%) | 2.01M (-14.10%) | 2.34M (-28.22%) | 3.26M (-81.21%) | 17M (+302.55%) | 4.31M (-5.48%) | 4.56M (-5.59%) | 4.83M (-16.58%) | 5.79M (+296.58%) | 1.46M (+1227.27%) | 110K | - |
Net Income | |||||||||||||||||||||||||||||||||
Income Before Tax | - | -190.89M | - | - | - | -257.15M | - | - | - | -327.26M | - | - | - | - | - | - | - | -257.00M | - | - | - | -68.57M (+3.58%) | -66.20M (+8.58%) | -60.97M (+11.91%) | -54.48M (-10.95%) | -61.18M (+20.67%) | -50.70M (+22.46%) | -41.40M (+30.85%) | -31.64M (+3.30%) | -30.63M (-29.59%) | -43.50M (-67.75%) | -134.90M (+5088.46%) | -2.60M |
Income Tax Expense | - | - | - | - | - | 440K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -150.00K | 30K | -160.00K (+220.00%) | -50.00K (-58.33%) | -120.00K | - | - | - |
Net Income From Continuing Operations | -42.61M (+9.79%) | -38.81M (-6.26%) | -41.40M (-18.73%) | -50.94M (-14.72%) | -59.73M (-0.35%) | -59.94M (-9.58%) | -66.29M (-0.11%) | -66.36M (+2.09%) | -65.00M (-24.22%) | -85.78M (+37.71%) | -62.29M (-21.38%) | -79.23M (-20.75%) | -99.97M (-2.59%) | -102.63M (+23.43%) | -83.15M (+11.18%) | -74.79M (-6.34%) | -79.85M | 90K | -78.19M (+10.22%) | -70.94M (+114.90%) | -33.01M (-51.86%) | -68.57M (+3.58%) | -66.20M (+8.58%) | -60.97M (+11.91%) | -54.48M (-10.73%) | -61.03M (+20.30%) | -50.73M (+23.01%) | -41.24M (+30.55%) | -31.59M (+3.54%) | -30.51M (-29.86%) | -43.50M (-67.75%) | -134.90M (+5088.46%) | -2.60M |
Net Income | -42.61M (+9.79%) | -38.81M (-6.26%) | -41.40M (-18.73%) | -50.94M (-14.72%) | -59.73M (-0.35%) | -59.94M (-9.58%) | -66.29M (-0.11%) | -66.36M (+2.09%) | -65.00M (-24.22%) | -85.78M (+37.71%) | -62.29M (-21.38%) | -79.23M (-20.75%) | -99.97M (-2.59%) | -102.63M (+23.43%) | -83.15M (+11.18%) | -74.79M (-6.34%) | -79.85M | 90K | -78.19M (+10.22%) | -70.94M (+114.90%) | -33.01M (-51.86%) | -68.57M (+3.58%) | -66.20M (+8.58%) | -60.97M (+11.91%) | -54.48M (-10.73%) | -61.03M (+20.30%) | -50.73M (+23.01%) | -41.24M (+30.55%) | -31.59M (+3.54%) | -30.51M (-29.86%) | -43.50M (-67.75%) | -134.90M (+5088.46%) | -2.60M |
Comprehensive Income Net Of Tax | -43.06M (-77.40%) | -190.53M (+363.35%) | -41.12M (-19.42%) | -51.03M (-14.38%) | -59.60M (-76.78%) | -256.72M (+292.78%) | -65.36M (-1.28%) | -66.21M (+1.91%) | -64.97M (-79.59%) | -318.29M (+423.07%) | -60.85M (-21.13%) | -77.15M (-19.62%) | -95.98M (-72.40%) | -347.77M (+310.93%) | -84.63M (+9.89%) | -77.01M (-11.00%) | -86.53M (-53.20%) | -184.89M (+136.28%) | -78.25M (+9.95%) | -71.17M (+113.21%) | -33.38M (-86.71%) | -251.10M (+274.38%) | -67.07M (+10.40%) | -60.75M (+12.48%) | -54.01M (-70.61%) | -183.75M (+260.08%) | -51.03M (+26.03%) | -40.49M (+32.80%) | -30.49M (-85.56%) | -211.20M (+383.96%) | -43.64M (-67.65%) | -134.90M (+5088.46%) | -2.60M |